Brief Title
The Relationship Between Post-ERCP-choledocholithiasis and Gallbladder Status
Official Title
Does the Gallbladder Status Influence the Occurence of Post-Endoscopic Retrograde Choledochopancreatography(ERCP) -Choledocholithiasis
Brief Summary
In this retrospective study, the investigators evaluate the relationship of post-ERCP-choledocholithiasis(PEC ) and the gallbladder status as a risk factor.
Detailed Description
When patients have common bile duct(CBD) stones, ERCP is widely used for stone extraction instead of clinical operation. ERCP has many advantages like less injury or faster recovery. However, according to literature, ERCP will has a mostly 10% possibility to get an acute purulent cholecystitis, which often requires emergency intervention, therefore, it is necessary to know if the gallbladder status(chronic disease) is one of the important risk factors of PEC like the gallbladder wall thickness, chronic cholecystitis, polyps,crudely or calculus. .
Study Type
Observational
Primary Outcome
Number of Acute PEC(post-ERCP-cholecystitis )
Secondary Outcome
Number of Participants with Pancreatitis
Condition
Cholecystitis
Intervention
ERCP
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
1117
Start Date
January 31, 2020
Completion Date
November 18, 2021
Primary Completion Date
November 18, 2021
Eligibility Criteria
Inclusion Criteria: - Routine ERCP for CBD stone patients with gallbladder in situ Exclusion Criteria: - Unwillingness or inability to consent for the study - Unstable vital signs Coagulation dysfunction (INR>1.5) and low peripheral blood platelet count (<50×10 ^9 / L) or using anti-coagulation drugs - Any Prior surgery for CBD including ERCP - Preoperative coexistent diseases: acute pancreatitis, GI tract hemorrhage, severe liver disease (such as decompensated liver cirrhosis, liver failure and so on), septic shock - Biliary- duodenal fistula confirmed during ERCP - Pregnant women or breastfeeding
Gender
All
Ages
18 Years - 90 Years
Accepts Healthy Volunteers
No
Contacts
Wenbo Meng, M.D., Ph. D., ,
Location Countries
China
Location Countries
China
Administrative Informations
NCT ID
NCT04234126
Organization ID
Gallbladder status and PEC
Responsible Party
Principal Investigator
Study Sponsor
Hepatopancreatobiliary Surgery Institute of Gansu Province
Study Sponsor
Wenbo Meng, M.D., Ph. D., Principal Investigator, Hepatopancreatobiliary Surgery Institute of Gansu Province
Verification Date
November 2021